{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:31:15Z","timestamp":1787333475268,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"DOI":"10.1007\/s12026-026-09829-4","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:36:52Z","timestamp":1787287012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hidden Burden: Liver and Gastrointestinal Involvement in Chronic Granulomatous Disease"],"prefix":"10.1007","volume":"74","author":[{"given":"Zehra","family":"Gen\u00e7 Ozbay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0562-9863","authenticated-orcid":false,"given":"Saliha","family":"Esenboga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Soyak Aytekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz \u0130lg\u00fcn","family":"G\u00fcrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersin","family":"G\u00fcm\u00fc\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayriye Hizarcioglu","family":"Gulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bar\u0131\u015f","family":"Ku\u015fkonmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130nci Nur","family":"Salt\u0131k-Temizel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"\u00d6zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fclya","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Cagdas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"2","key":"9829_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12016-020-08800-x","volume":"61","author":"HH Yu","year":"2021","unstructured":"Yu HH, Yang YH, Chiang BL. Chronic Granulomatous Disease: a Comprehensive Review. Clin Rev Allergy Immunol. 2021;61(2):101\u201313.","journal-title":"Clin Rev Allergy Immunol"},{"key":"9829_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/978-1-4939-9424-3_32","volume":"1982","author":"D Roos","year":"2019","unstructured":"Roos D. Chronic Granulomatous Disease. Methods Mol Biol. 2019;1982:531\u201342.","journal-title":"Methods Mol Biol"},{"issue":"3","key":"9829_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.29262\/ram.v68i3.860","volume":"68","author":"M Toledo","year":"2021","unstructured":"Toledo M, Campos A, Scheffler-Mendoza S, et al. [Infectious and inflammatory gastrointestinal manifestations of chronic granulomatous disease]. Rev Alerg Mex. 2021;68(3):198\u2013205.","journal-title":"Rev Alerg Mex"},{"issue":"5","key":"9829_CR4","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1007\/s10875-021-01002-w","volume":"41","author":"HT Akar","year":"2021","unstructured":"Akar HT, Esenboga S, Cagdas D, et al. Clinical and Immunological Characteristics of 63 Patients with Chronic Granulomatous Disease: Hacettepe Experience. J Clin Immunol. 2021;41(5):992\u20131003.","journal-title":"J Clin Immunol"},{"key":"9829_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/978-1-4939-9424-3_34","volume":"1982","author":"EL Falcone","year":"2019","unstructured":"Falcone EL, Holland SM. Gastrointestinal Complications in Chronic Granulomatous Disease. Methods Mol Biol. 2019;1982:573\u201386.","journal-title":"Methods Mol Biol"},{"issue":"5","key":"9829_CR6","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.jaip.2022.12.039","volume":"11","author":"AH Yang","year":"2023","unstructured":"Yang AH, Sullivan B, Zerbe CS, et al. Gastrointestinal and Hepatic Manifestations of Chronic Granulomatous Disease. J Allergy Clin Immunology: Pract. 2023;11(5):1401\u201316.","journal-title":"J Allergy Clin Immunology: Pract"},{"issue":"1","key":"9829_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.14090","volume":"1450","author":"MN Garcia-Casal","year":"2019","unstructured":"Garcia-Casal MN, Pasricha SR, Sharma AJ, Pe\u00f1a-Rosas JP. Use and interpretation of hemoglobin concentrations for assessing anemia status in individuals and populations: results from a WHO technical meeting. Ann N Y Acad Sci. 2019;1450(1):5\u201314.","journal-title":"Ann N Y Acad Sci"},{"key":"9829_CR8","unstructured":"BERKEL A\u0130, \u0130lhan T, F\u00fcgen E, \u00d6zden S. \u0130mm\u00fcnoglobulin-g subklaslar\u0131n\u0131n T\u00fcrk \u00e7ocuklar\u0131 ve eri\u015fkinlerdeki de\u011ferlerinin ara\u015ft\u0131r\u0131lmas\u0131. 1992."},{"issue":"5","key":"9829_CR9","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","volume":"112","author":"WT Shearer","year":"2003","unstructured":"Shearer WT, Rosenblatt HM, Gelman RS, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112(5):973\u201380.","journal-title":"J Allergy Clin Immunol"},{"key":"9829_CR10","first-page":"76","volume":"450","author":"WHO Child Growth","year":"2006","unstructured":"WHO Child Growth. Standards based on length\/height, weight and age. Acta Paediatr Suppl. 2006;450:76\u201385.","journal-title":"Acta Paediatr Suppl"},{"issue":"9","key":"9829_CR11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2471\/BLT.07.043497","volume":"85","author":"M de Onis","year":"2007","unstructured":"de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85(9):660\u20137.","journal-title":"Bull World Health Organ"},{"key":"9829_CR12","first-page":"1","volume":"854","author":"Physical status","year":"1995","unstructured":"Physical status. the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1\u2013452.","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"3","key":"9829_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/hep.21524","volume":"45","author":"N Hussain","year":"2007","unstructured":"Hussain N, Feld JJ, Kleiner DE, et al. Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology. 2007;45(3):675\u201383.","journal-title":"Hepatology"},{"issue":"7","key":"9829_CR14","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1053\/j.gastro.2008.02.081","volume":"134","author":"JJ Feld","year":"2008","unstructured":"Feld JJ, Hussain N, Wright EC, et al. Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. Gastroenterology. 2008;134(7):1917\u201326.","journal-title":"Gastroenterology"},{"issue":"4","key":"9829_CR15","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3390\/jcm13041092","volume":"13","author":"A Grammatikos","year":"2024","unstructured":"Grammatikos A, Gennery AR. Inflammatory Complications in Chronic Granulomatous Disease. J Clin Med. 2024;13(4):1092.","journal-title":"J Clin Med"},{"issue":"5","key":"9829_CR16","doi-asserted-by":"publisher","first-page":"552","DOI":"10.5152\/TurkArchPediatr.2025.24231","volume":"60","author":"GA Yigit","year":"2025","unstructured":"Yigit GA, Sonmez G, Deveci K, et al. Osteomyelitis with a Pathologic Fracture, Mortal Liver Abscess, and Cholelithiasis: Distinct Features in two Families with the Same p47-phox Mutation. Turk Arch Pediatr. 2025;60(5):552\u20136.","journal-title":"Turk Arch Pediatr"},{"issue":"3","key":"9829_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: Pathophysiological basis for therapy. J Hepatol. 2020;72(3):558\u201377.","journal-title":"J Hepatol"},{"issue":"7","key":"9829_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","volume":"15","author":"A Tripathi","year":"2018","unstructured":"Tripathi A, Debelius J, Brenner DA, et al. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018;15(7):397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"9829_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1572-0241.2006.00947.x","volume":"102","author":"FD Mendes","year":"2007","unstructured":"Mendes FD, Levy C, Enders FB, Loftus EV Jr., Angulo P, Lindor KD. Abnormal hepatic biochemistries in patients with inflammatory bowel disease. Am J Gastroenterol. 2007;102(2):344\u201350.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"9829_CR20","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.jaci.2023.07.022","volume":"152","author":"P Chandrasekaran","year":"2023","unstructured":"Chandrasekaran P, Han Y, Zerbe CS, et al. Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease. J Allergy Clin Immunol. 2023;152(6):1619\u20131633.e11","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9829_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/imr.13308","volume":"322","author":"CS Zerbe","year":"2024","unstructured":"Zerbe CS, Holland SM. Functional neutrophil disorders: Chronic granulomatous disease and beyond. Immunol Rev. 2024;322(1):71\u201380.","journal-title":"Immunol Rev"},{"issue":"2","key":"9829_CR22","first-page":"287","volume":"45","author":"C McKinney","year":"2025","unstructured":"McKinney C, Ambruso D. Non-Infectious Complications of Chronic Granulomatous Disease: Knowledge Gaps & Novel Treatment Considerations. Immunol Allergy Clin. 2025;45(2):287\u201398.","journal-title":"Immunol Allergy Clin"},{"key":"9829_CR23","doi-asserted-by":"publisher","first-page":"102587","DOI":"10.1016\/j.bcmd.2021.102587","volume":"90","author":"D Roos","year":"2021","unstructured":"Roos D, van Leeuwen K, Hsu AP, et al. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update). Blood Cells Molecules Dis. 2021;90:102587.","journal-title":"Blood Cells Molecules Dis"},{"issue":"12","key":"9829_CR24","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1111\/jgh.16342","volume":"38","author":"S Bhattacharya","year":"2023","unstructured":"Bhattacharya S, Wong U, Khalid M, et al. Small bowel disease prevalence on video capsule endoscopy in chronic granulomatous disease-associated inflammatory bowel disease. J Gastroenterol Hepatol. 2023;38(12):2083\u20139.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"9829_CR25","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.jaip.2021.12.035","volume":"10","author":"B LaBere","year":"2022","unstructured":"LaBere B, Gutierrez MJ, Wright H, et al. Chronic Granulomatous Disease With Inflammatory Bowel Disease: Clinical Presentation, Treatment, and Outcomes From the USIDNET Registry. J Allergy Clin Immunol Pract. 2022;10(5):1325\u20131333.e5","journal-title":"J Allergy Clin Immunol Pract"},{"key":"9829_CR26","doi-asserted-by":"publisher","first-page":"1384550","DOI":"10.3389\/fped.2024.1384550","volume":"12","author":"O Staudacher","year":"2024","unstructured":"Staudacher O, von Bernuth H. Clinical presentation, diagnosis, and treatment of chronic granulomatous disease. Front Pediatr. 2024;12:1384550.","journal-title":"Front Pediatr"},{"issue":"12","key":"9829_CR27","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1086\/657308","volume":"51","author":"G Uzel","year":"2010","unstructured":"Uzel G, Orange JS, Poliak N, Marciano BE, Heller T, Holland SM. Complications of tumor necrosis factor-\u03b1 blockade in chronic granulomatous disease-related colitis. Clin Infect Dis. 2010;51(12):1429\u201334.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"9829_CR28","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1056\/NEJM200103223441203","volume":"344","author":"ME Horwitz","year":"2001","unstructured":"Horwitz ME, Barrett AJ, Brown MR, et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med. 2001;344(12):881\u20138.","journal-title":"N Engl J Med"},{"issue":"13","key":"9829_CR29","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1182\/blood-2002-02-0583","volume":"100","author":"RA Seger","year":"2002","unstructured":"Seger RA, Gungor T, Belohradsky BH, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985\u20132000. Blood. 2002;100(13):4344\u201350.","journal-title":"Blood"},{"issue":"3","key":"9829_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","volume":"79","author":"JA Winkelstein","year":"2000","unstructured":"Winkelstein JA, Marino MC, Johnston RBJ, et al. Chronic Granulomatous Disease: Report on a National Registry of 368 Patients. Medicine. 2000;79(3):155\u201369.","journal-title":"Medicine"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09829-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09829-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09829-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:03:35Z","timestamp":1787331815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09829-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9829"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09829-4","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"16 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Hacettepe University Health Sciences Research Ethics Committee (approval number: 2026\/01\u201338; research number: SBA 26\/040; approval date: January 6, 2026). The study was conducted in accordance with the Declaration of Helsinki. Due to the retrospective nature of the study, the requirement for informed consent was waived by the ethics committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"92"}}